236 related articles for article (PubMed ID: 16575201)
1. TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFRbeta.
Zhong L; Guo XN; Zhang XH; Sun QM; Tong LJ; Wu ZX; Luo XM; Jiang HL; Nan FJ; Zhang XW; Lin LP; Ding J
Cancer Biol Ther; 2006 Mar; 5(3):323-30. PubMed ID: 16575201
[TBL] [Abstract][Full Text] [Related]
2. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1.
Lin B; Song X; Yang D; Bai D; Yao Y; Lu N
Gene; 2018 May; 654():77-86. PubMed ID: 29454091
[TBL] [Abstract][Full Text] [Related]
3. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
Ji L; Wu M; Li Z
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
[TBL] [Abstract][Full Text] [Related]
4. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
5. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
6. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
8. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
9. Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway.
Komi Y; Sogabe Y; Ishibashi N; Sato Y; Moriwaki H; Shimokado K; Kojima S
Lab Invest; 2010 Jan; 90(1):52-60. PubMed ID: 19841617
[TBL] [Abstract][Full Text] [Related]
10. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
Pan R; Dai Y; Gao XH; Lu D; Xia YF
Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
[TBL] [Abstract][Full Text] [Related]
12. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.
Ma Q; Chen W; Chen W
Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645
[TBL] [Abstract][Full Text] [Related]
14. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
[TBL] [Abstract][Full Text] [Related]
15. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets.
Yin X; Lin X; Ren X; Yu B; Liu L; Ye Z; Chen Q; Lee C; Lu W; Yu D; Li X
Pharmacol Res; 2019 Aug; 146():104277. PubMed ID: 31112749
[TBL] [Abstract][Full Text] [Related]
16. Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling.
Lu J; Zhang K; Nam S; Anderson RA; Jove R; Wen W
Carcinogenesis; 2010 Mar; 31(3):481-8. PubMed ID: 19969552
[TBL] [Abstract][Full Text] [Related]
17. LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo.
Zhao K; Yuan Y; Lin B; Miao Z; Li Z; Guo Q; Lu N
Gene; 2018 Feb; 642():533-541. PubMed ID: 29196258
[TBL] [Abstract][Full Text] [Related]
18. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]